The IQSEC1 Knockout NCI-H1975 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population designed to disrupt the IQSEC1 gene in the NCI-H1975 human lung adenocarcinoma epithelial cell line. This loss-of-function model enables precise interrogation of IQSEC1-dependent mechanisms in a physiologically relevant EGFR-mutant lung cancer background. The polyclonal format reflects a genetically heterogeneous knockout population generated by CRISPR/Cas9-mediated gene disruption, providing a robust tool for studying gene function without clonal selection.
The NCI-H1975 host cell line was derived from the pleural effusion of a female patient with non-small cell lung cancer and harbors activating EGFR L858R and T790M mutations. These molecular features establish NCI-H1975 as a widely used model for EGFR-mutant lung adenocarcinoma, particularly for investigating acquired resistance to first- and third-generation tyrosine kinase inhibitors. The cell line??s epithelial origin and genetic background make it suitable for dissecting signaling networks that drive tumor progression, metastasis, and therapeutic escape.
IQSEC1 encodes a guanine nucleotide exchange factor (GEF) for the small GTPase Arf6, playing a central role in integrin trafficking, cell adhesion, and migration. IQSEC1 is activated by upstream signals from EGFR, PDGFR, and GPCRs, as well as Src kinase and PI3K, and functions to promote Arf6 GTP loading. Active Arf6 regulates the endocytosis and recycling of ??1 integrin, thereby modulating focal adhesion dynamics through FAK. IQSEC1 interacts with ??-arrestin, clathrin, and the AP-2 adaptor complex to coordinate receptor trafficking and integrin turnover. This network positions IQSEC1 at the intersection of growth factor signaling and cell-extracellular matrix interactions.
Within the NCI-H1975 context, IQSEC1 disruption is predicted to impair Arf6-dependent integrin recycling, leading to reduced cell adhesion, migration, and invasion. Since EGFR trafficking and signaling are partly governed by integrin-mediated adhesion, loss of IQSEC1 may also alter EGFR localization and downstream pathway activation, potentially sensitizing cells to EGFR inhibitors or modifying metastatic behavior. This makes the knockout model particularly valuable for deciphering how integrin trafficking cross-talks with oncogenic EGFR signaling in drug-resistant lung adenocarcinoma.
Researchers can employ these polyclonal knockout cells in a variety of functional assays, including transwell migration and wound healing assays to assess motility, integrin recycling and cell adhesion assays to quantify trafficking and attachment, and Western blotting for Arf6-GTP levels or phospho-analysis of EGFR signaling components. Immunofluorescence-based localization of integrins and FAK further elucidates adhesion dynamics. The model supports investigations into cancer metastasis, EGFR inhibitor resistance, and lung adenocarcinoma biology. For additional information regarding custom applications, please contact Ascent Research.
